MAI Wealth Advisors »

Atea Pharmaceuticals shares owned by MAI Wealth Advisors

Quarter-by-quarter ownership of Atea Pharmaceuticals (AVIR) shares owned by MAI Wealth Advisors from 13F filings

Historical chart of MAI Wealth Advisors investment in Atea Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Atea Pharmaceuticals held by MAI Wealth Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atea Pharmaceuticals by MAI Wealth Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $339 95 3.58
2025-09-30 $276 95 2.91
2025-06-30 $342 95 3.60
2025-03-31 $285 95 3.00
2024-12-31 $319 95 3.36

More positions owned by MAI Wealth Advisors

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Call Call Option (Principal) (SPY)
Apple Call Call Option (Principal) (AAPL)
Microsoft Corp Call Call Option (Principal) (MSFT)
Ishares Tr Core S&p Mcp Etf (IJH)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Alphabet Call Call Option (Principal) (GOOGL)
Amazon Call Call Option (Principal) (AMZN)
Invesco Qqq Tr Call Call Option (Principal) (QQQ)
Ishares Tr Core S&p Scp Etf (IJR)
Vanguard Specialized Funds Div App Etf (VIG)
Ishares Tr S&p 500 Val Etf (IVE)
Broadcom Call Call Option (Principal) (AVGO)
Ishares Tr Core Msci Eafe (IEFA)

View all positions for MAI Wealth Advisors

Top funds holding Atea Pharmaceuticals

BlackRock
BML Capital Management
FMR
Tang Capital Management
Vanguard Group
Bain Capital Life Sciences Investors
Geode Capital Management
State Street Corporation
Dimensional Fund Advisors
Acadian Asset Management
Renaissance Technologies
Two Sigma Advisers
Jpmorgan Chase & Co
Charles Schwab Investment Management
Northern Trust

View all funds holding Atea Pharmaceuticals